A carregar...

450. Evaluation of Linezolid Pharmacokinetics in Obese Patients with Severe Skin and Soft-Tissue Infections

BACKGROUND: Linezolid is an oxazolidinone antibiotic with broad activity against Gram-positive bacteria and serves as an option for treating severe skin and soft-tissue infections (SSTIs). Adult FDA-labeled dosing is fixed at 600 mg IV/PO twice daily. Although conflicting, current literature is sugg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Blackman, Alison L, Jarugula, Praneeth, Nicolau, David P, Ho Chui, Sai, Joshi, Manjari, Gopalakrishnan, Mathangi, Heil, Emily
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809085/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.523
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!